Siba El Hussein, MD on X: "Daratumumab, an anti-CD38 IgG Kappa antibody, can cause light chain restriction in hematogones, proposed mechanism shown in video below: #hemepath #pathtwitter #mmsm @KirillLyapichev @sanamloghavi @KMirza ...
Development of oligoclonal band (OB) in a patient with IgGκ myeloma... | Download Scientific Diagram
Daratumumab for Severe Refractory Proliferative Glomerulonephritis with Monoclonal Immune Deposits (PGNMID). - ATC Abstracts
Types of Multiple Myeloma | International Myeloma Foundation
Artifactual Kappa Light Chain Restriction of Marrow Hematogones: A Potential Diagnostic Pitfall in Minimal Residual Disease Assessment of Plasma Cell Myeloma Patients on Daratumumab - Jiang - 2020 - Cytometry Part B:
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Frontiers | Essentially Leading Antibody Production: An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab Variants